Back to News

Advanced Therapies – Virtual

Advanced Therapies is the world’s largest commercially focused ATMP event which will be online from May 19 to 21, 2021

Magali Taiel, Chief Medical Officer at GenSight Biologics, will chair a roundtable on “Neurological & ophthalmic applications for ATMPs” on Day 1 Wednesday 19 May, 2.30pm BST.

Dr Taiel wil also give an oral presentation on ” Lumevoq gene therapy in Leber Hereditary Optic Neuropathy “, streaming from Day 2 Thursday, May 20, 2021 4:30 PM BST to Day 3 Friday, May 21, 2022 12:00 PM BST.

 

 

Back to News

A New Chapter

Founded in 2012 to realize the potential of gene therapy, GenSight Biologics has grown into a clinical-stage company advancing multiple programs. In 2024, under a new management team, the company entered a new phase and is now accelerating its clinical and regulatory activities.

Explore investors’ hub

GenSight Biologics S.A.
74 rue du Faubourg Saint-Antoine
75012 Paris
France